Emergency Medicine Cardiac Research and Education Group






CONTINUUM OF CARE FOR ACUTE CORONARY SYNDROME: OPTIMIZING TREATMENT FOR NSTE-ACS AND STEMI

In this EMCREG-International Monograph, Continuum of Care for Acute Coronary Syndrome: Optimizing Treatment for STEMI and NSTE-ACS, you will find a detailed discussion regarding the treatment of this important disease entity, acute coronary syndrome (ACS), which impacts millions of patients across the United States each year. This is a “state of the art” Monograph for emergency physicians, cardiologists, and hospitalists which provides the evidence basis for the optimal approach to treating non-ST-elevation acute coronary syndrome (NSTE-ACS) and ST-elevation myocardial infarction (STEMI).

CONTINUUM OF CARE FOR ACUTE CORONARY SYNDROME: OPTIMIZING TREATMENT FOR NSTE-ACS AND STEMI

ADVANCES IN THE TREATMENT OF STABLE CORONARY ARTERY DISEASE AND PERIPHERAL ARTERY DISEASE

In this EMCREG-International Monograph, Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease, you will find a detailed discussion regarding the treatment of these two critically important disease entities. This is a Proceedings Monograph based on the 2017 EMCREG-International Satellite Symposium which was held on November 12, 2017, in Anaheim during the American Heart Association Scientific Sessions. For cardiologists, internists, family physicians, hospitalists and emergency physicians, the current approach and evolution of treatment for stable coronary artery disease (CAD) and peripheral artery disease (PAD) are particularly relevant and represent a fertile area for improving care for these patients.

ADVANCES IN THE TREATMENT OF STABLE CORONARY ARTERY DISEASE AND PERIPHERAL ARTERY DISEASE
EMCREG SYMPOSIUM at the AHA 2017

MISS AT THE 2017 AHA? NOT A PROBLEM. Post event CME monograph out in February.
Monographs distributed to members of the American Heart Association, American Colege of Emergency Physicians, Socitey of Hospital Medicine and Society of Emergency Physician Assistants by default. If you would like a copy please contact us.

Speaker PDF slidesets below!

PROGRAM CHAIRS and FACULTY:

Christopher B. Granger, MD (Chair) - Duke University Medical Center
W. Brian Gibler, MD (Co-Chair) - President, EMCREG-International, University of Cincinnai

FACTOR Xa MECHANISM OF ACTION - IMPACT ON THE CLOTTING CASCADE, TISSUE FACTOR-INITIATED CLOTTING, INFLAMMATION, AND PLATELET ACTIVATION
Richard C. Becker, MD
University of Cincinnati College of Medicine, Cincinnati, OH
[DOWNLOAD SLIDESET]

DECREASING MAJOR ADVERSE CLINICAL EVENTS FOR PATIENTS WITH CORONARY ARTERY DISEASE AND PERIPHERAL ARTERY DISEASE: THE COMPASS TRIAL
Deepak L. Bhatt, MD, MPH
Duke University Medical Center, Durham, NC
[DOWNLOAD SLIDESET]

IMPROVING THE TREATMENT OF PERIPHERAL ARTERY DISEASE: PROVIDING INDIVIDUALIZED, INNOVATIVE, AND EFFICIENT CARE
Manesh R. Patel, MD
Duke University, Durham, NC
[DOWNLOAD SLIDESET]

CLINICAL AND ECONOMIC VALUE OF RIVAROXABAN IN CORONARY ARTERY DISEASE
Christopher B. Granger, MD
Duke University Medical Center, Durham, NC
[DOWNLOAD SLIDESET]
 

IMPACT OF HIGH SENSITIVITY TROPONIN ON THE EVALUATION AND TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IMPACT OF HIGH SENSITIVITY TROPONIN ON THE EVALUATION AND TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
In this EMCREG-International Monograph, Impact of High Sensitivity Troponin on the Evaluation and Treatment of Acute Coronary Syndrome, you will find a detailed discussion regarding the use of high sensitivity troponin assays in patients presenting to the hospital with ACS from multiple perspectives including Emergency Medicine, Cardiology, Hospital Medicine, Laboratory Medicine, and Emergency Nursing. High sensitivity assays for troponin have been available for clinical use in Europe for the past decade and proved to be critical for the early diagnosis of acute myocardial necrosis in patients presenting to the emergency department (ED) with possible ACS and defining treatment for these patients which includes anti-platelet and anti-coagulant agents, as well as cardiologist intervention. In March 2017, high sensitivity cardiac troponin T was approved by the FDA for routine clinical use in the United States. Clearly many clinicians and laboratorians in the US have not had experience with high sensitivity troponin assays which has identified an important educational area for emphasis. This information on high sensitivity troponin becomes extremely important to emergency physicians, cardiologists, hospitalists, laboratorians, physician assistants, nurse practitioners, and emergency nurses as they routinely care for these often critically-ill patients.

View the monograph.

OPTIMAL THERAPY FOR ACS: USING GUIDELINE-BASED TREATMENTS IN THE EMERGENCY SETTING
OPTIMAL THERAPY FOR ACS: USING GUIDELINE-BASED TREATMENTS IN THE EMERGENCY SETTING
In this EMCREG-International Monograph, you will find a variety of cardiovascular articles which will hopefully be helpful to you in your practice of Emergency Medicine and Acute Care Medicine. These manuscripts are based on the 2015 EMCREG-International Satellite Symposium which was held on October 25, 2015, during the 2015 ACEP Scientific Assembly in Boston, Massachusetts. The symposium and this Monograph entitled Optimal Therapy for Acute Coronary Syndromes: Using Guideline-Based Treatments in the Emergency Setting explore multiple Acute Coronary Syndrome (ACS) topics which are extremely important to emergency physicians, hospitalists, and other acute care providers such as physician assistants and nurse practitioners as they care for these often critically-ill patients.

View the monograph.


Legal information

EMCREG™ - International Department of Emergency Medicine

231 Albert Sabin Way
MSB Suite 1358F
Cincinnati, Ohio 45267-0769

Fell free to contact us at support@emcreg.org
or toll-free at 1-855-678-5061



Advanced Search
©Copyright EMCREG-International™ 2014. All rights reserved